Global Non-insulin Therapies for Diabetes Market: Growth Analysis & Projection, Forecast 2021| Eli Lilly and Company, Eurofarma Laboratories S.A., GlaxoSmithKline plc

The global rise in people suffering from type 2 diabetes is expected to drive the global non-insulin therapies for diabetes market. The global non-insulin therapies for diabetes market is estimated to reach a market value of US$ 64,590.6 million in 2021 and it is expected to reach US$ 105,461.5 million by 2030, growing at an estimated CAGR of 6.3% over the forecast period.
Globally, diabetes is considered to be the most common disease and is ranked as top ten fatal disease in the U.S. Non-insulin therapies are frequently used in type 2 diabetes, accounting more than 90.0% of the diabetes cases. The rising economic burden of diabetes is substantially very high and is expected to surge in the coming future.

Request For a Sample Copy@ https://www.absolutemarketsinsights.com/request_sample.php?id=259

Across the globe, several regions such as North America, Latin America, Asia-Pacific, Europe, and Africa have been examined on the basis of the productivity of the companies. Different leading industries have been profiled to get accurate guidelines from successful companies. Emerging countries are primary regions for increasing the outcome of the industries. According to this research report, strategies have been elaborated to understand global trading.

Enquiry before Buying@ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=259

Non-insulin Therapies for Diabetes Market Key Findings:
• Oral product market segment held nearly 90 % of market share in 2021 and is estimated to grow at CAGR of above 6.5% during the forecast period. The growth is attributed to new approvals by the FDA.
• Injectable market is estimated to grow with CAGR of 4.9% over the projection timeframe, owing to ongoing research & development of injectable and rise in adoption of combination therapies.
• In 2021, the U.S. region in the non-insulin therapies for diabetes market accounted for highest revenue share. The high share is attributed to the presence of pharmaceutical companies engaged in the research & development for the treatment of type 2 diabetes.
• Asia Pacific region non-insulin therapies for diabetes market is expected to witness the highest growth rate of 7.2% over the forecast period. The presence of huge type 2 diabetic population will contribute to market growth in this region.

Key industry participants in the global non-insulin therapies for diabetes market:
Eli Lilly and Company, Eurofarma Laboratorios S.A., GlaxoSmithKline plc, Merck Sharp & Dohme Corp. (subsidiary of Merck & Co., Inc), Novo Nordisk Luye Pharma Group, and Pfizer Inc. among others.

Ask For Customization@ https://www.absolutemarketsinsights.com/request_for_customization.php?id=259

Non-insulin Therapies for Diabetes Market Key Market Segment:
By Product:
• Oral
o Thiazolidinediones (TZDs)
o Insulin secretagogues
o Alpha-glucosidase inhibitors (AGIs)
o Sulfonylureas
o Dipeptidyl peptidase-4 (DPP-4) inhibitors
o Sodium-glucose cotransporter-2 (SGLT2) inhibitors
o Glinides/Meglitinides
o Metformin
o Biguanides
o Others
• Injectable
o Glucagon-like peptide-1 (GLP-1) agonists
o Amylin Agonists
o Others

By Distributor:
• Hospital Pharmacy
• Retail Pharmacies
• Online Pharmacy
• Others

By Geography:
• North America
o U.S.
o Canada
o Mexico
o Rest of North America
• Asia Pacific
o China
o Japan
o India
o New Zealand
o Australia
o South Korea
o Southeast Asia
 Indonesia
 Thailand
 Malaysia
 Singapore
 Rest of Southeast Asia
o Rest of Asia Pacific
• Europe
o France
o The UK
o Spain
o Germany
o Italy
o Nordic Countries
 Denmark
 Finland
 Iceland
 Sweden
 Norway
o Benelux Union
 Belgium
 The Netherlands
 Luxembourg
o Rest of Europe
• Middle East and Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa
• Latin America
o Argentina
o Brazil
o Rest of Latin America
For more details:
https://www.absolutemarketsinsights.com/reports/Global-Non-insulin-Therapies-for-Diabetes-Market-2019-2027-259

Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/

About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

This release was published on openPR.